Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VECTUS BIOSYSTEMS LIMITED Director's Dealing 2022

Dec 29, 2022

65993_rns_2022-12-29_0caa2a96-d1d2-426e-bce8-83f1c49e5f72.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Vectus Biosystems Limited (ASX:VBS) ABN 54 117 526 137

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Maurie Stang
Date of last notice 4 October 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances
giving rise to the relevant interest.
Energy Trading Systems Pty Ltd
Maurie Stang is the sole shareholder of the trustee,
Energy Trading Systems Pty Ltd, and he is a beneficiary
of The MPF Trust.
Meditsuper Pty Ltd
Maurie Stang is a 50% holder in the trust.
Maurie Stang is a 50% shareholder of each of the
following companies:
Stangcorp Pty Ltd
Epitek Corporation Pty Ltd
247 Church Street Pty Ltd
Ramlist Pty Ltd
Regional Health Care Group Pty Ltd
Teknik Pty Ltd
Date of change 28 December 2022
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held
prior to change
2,550,000 fully paid ordinary shares in the name of
Energy Trading Systems Pty Ltd
2,285,952 fully paid ordinary shares in the name of
Maurie Stang
1,500 fully paid ordinary shares in the name of
Meditsuper Pty Ltd
1,500 fully paid ordinary shares in the name of
Stangcorp Pty Ltd
1,500 fully paid ordinary shares in the name of
Epitek Corporation Pty Ltd
1,500 fully paid ordinary shares in the name of
247 Church Street Pty Ltd
1,500 fully paid ordinary shares in the name of
Ramlist Pty Ltd
1,500 fully paid ordinary shares in the name of
Regional Health Care Group Pty Ltd
1,500 fully paid ordinary shares in the name of
Teknik Pty Ltd
Class Fully paid ordinary shares
Number acquired 12,500 fully paid ordinary shares (in the name of Energy
TradingSystems PtyLtd )
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide
details and estimated valuation
$10,000 at a price of $0.80 per share
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change 2,562,500 fully paid ordinary shares in the name of
Energy Trading Systems Pty Ltd
2,285,952 fully paid ordinary shares in the name of
Maurie Stang
1,500 fully paid ordinary shares in the name of
Meditsuper Pty Ltd
1,500 fully paid ordinary shares in the name of
Stangcorp Pty Ltd
1,500 fully paid ordinary shares in the name of
Epitek Corporation Pty Ltd
1,500 fully paid ordinary shares in the name of
247 Church Street Pty Ltd
1,500 fully paid ordinary shares in the name of
Ramlist Pty Ltd
1,500 fully paid ordinary shares in the name of
Regional Health Care Group Pty Ltd
1,500 fully paid ordinary shares in the name of
Teknik Pty Ltd
Nature of change
Example: on-market trade, off-market trade,
exercise of options, issue of securities under
dividend reinvestment plan, participation in
buy-back
Issue of shares under Share Purchase Plan

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract None
Nature of interest
Name of registered holder (if issued securities)
**Date of change **
No. and class of securities to which interest related prior to change
Note: Details are onlyrequired for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 – +Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed No period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3